TNDM — Tandem Diabetes Care, Inc.

Healthcare • Medical - Devices

$14.00
-0.59 (—%)

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Company

Ticker
TNDM
Exchange
Sector
Healthcare
Industry
Medical - Devices
Country
US
CEO
John F. Sheridan
Employees
2650
Website
www.tandemdiabetes.com

Price

Showing 1Y history. Source: FMP “historical price full”.

Prev Close
$14.59
Day High
$14.29
Day Low
$13.66
52w High
$38.28
52w Low
$9.98
Volume
1,645,009
Avg Volume
Beta
1.489

Key Metrics

Market Cap
946M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available